Home
/ Corium
/ Competitors

Corium Competitors and Similar CompaniesClear all

Corium's competitors and similar companies include Mankind Pharma, Genentech, Alembic Pharmaceuticals and UCB.

	Corium Corium is a commercial-stage biopharmaceutical company leading the development of new transdermal healthcare products.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 1999	Founding Date 1995	Founding Date 1976	Founding Date 2010	Founding Date 1928
Type	Type Private	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Menlo Park, US HQ Boston, US Kentwood, US	Locations New Delhi, IN HQ	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 3255% increase	Employees 16,2532% increase	Employees 18,077	Employees 14,858	Employees 9,052
Financial
Revenue (est.)	Revenue (est.) $31.9m (FY, 2017)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹73.4b (FY, 2026)	Revenue (est.) €7.4b (FY, 2025)
Cost of goods	Cost of goods $15m (FY, 2017)	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)	Cost of goods €1.4b (FY, 2025)
Gross profit	Gross profit $16.8m (FY, 2017)	Gross profit N/A	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)	Gross profit €7.2b (FY, 2025)
Net income	Net income ($47.8m) (FY, 2017)	Net income N/A	Net income N/A	Net income ₹6.7b (FY, 2026)	Net income €1.6b (FY, 2025)
Funding
Total funding raised	Total funding raised $ 40m	Total funding raised $ 239m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A